These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 32117051)

  • 1. Both JNK1 and JNK2 Are Indispensable for Sensitized Extracellular Matrix Mineralization in IKKβ-Deficient Osteoblasts.
    Hao Q; Liu Z; Lu L; Zhang L; Zuo L
    Front Endocrinol (Lausanne); 2020; 11():13. PubMed ID: 32117051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of hepatic NF-kappa B activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activation.
    Sakurai T; Maeda S; Chang L; Karin M
    Proc Natl Acad Sci U S A; 2006 Jul; 103(28):10544-51. PubMed ID: 16807293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-Jun N-Terminal Kinases (JNKs) Are Critical Mediators of Osteoblast Activity In Vivo.
    Xu R; Zhang C; Shin DY; Kim JM; Lalani S; Li N; Yang YS; Liu Y; Eiseman M; Davis RJ; Shim JH; Greenblatt MB
    J Bone Miner Res; 2017 Sep; 32(9):1811-1815. PubMed ID: 28561373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TAOK3 is a MAP3K contributing to osteoblast differentiation and skeletal mineralization.
    Li Z; Oh H; Cung M; Marquez SJ; Sun J; Hammad H; Janssens S; Pouliot P; Lambrecht BN; Yang YS; Shim JH; Greenblatt MB
    Biochem Biophys Res Commun; 2020 Oct; 531(4):497-502. PubMed ID: 32807497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic deletion of JNK1 and JNK2 aggravates the DSS-induced colitis in mice.
    Chromik AM; Müller AM; Körner J; Belyaev O; Holland-Letz T; Schmitz F; Herdegen T; Uhl W; Mittelkötter U
    J Invest Surg; 2007; 20(1):23-33. PubMed ID: 17365404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. c-Jun N-terminal kinase 1 is deleterious to the function and survival of murine pancreatic islets.
    Varona-Santos JL; Pileggi A; Molano RD; Sanabria NY; Ijaz A; Atsushi M; Ichii H; Pastori RL; Inverardi L; Ricordi C; Fornoni A
    Diabetologia; 2008 Dec; 51(12):2271-80. PubMed ID: 18853132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. JNK inactivation suppresses osteogenic differentiation, but robustly induces osteopontin expression in osteoblasts through the induction of inhibitor of DNA binding 4 (Id4).
    Kusuyama J; Amir MS; Albertson BG; Bandow K; Ohnishi T; Nakamura T; Noguchi K; Shima K; Semba I; Matsuguchi T
    FASEB J; 2019 Jun; 33(6):7331-7347. PubMed ID: 30884976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. c-Jun N-terminal protein kinase 1 (JNK1), but not JNK2, is essential for tumor necrosis factor alpha-induced c-Jun kinase activation and apoptosis.
    Liu J; Minemoto Y; Lin A
    Mol Cell Biol; 2004 Dec; 24(24):10844-56. PubMed ID: 15572687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional in vivo interactions between JNK1 and JNK2 isoforms in obesity and insulin resistance.
    Tuncman G; Hirosumi J; Solinas G; Chang L; Karin M; Hotamisligil GS
    Proc Natl Acad Sci U S A; 2006 Jul; 103(28):10741-6. PubMed ID: 16818881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. JNK activity is essential for Atf4 expression and late-stage osteoblast differentiation.
    Matsuguchi T; Chiba N; Bandow K; Kakimoto K; Masuda A; Ohnishi T
    J Bone Miner Res; 2009 Mar; 24(3):398-410. PubMed ID: 19016586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cooperation between JNK1 and JNK2 in activation of p53 apoptotic pathway.
    Oleinik NV; Krupenko NI; Krupenko SA
    Oncogene; 2007 Nov; 26(51):7222-30. PubMed ID: 17525747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. JNK1, but not JNK2, is required for COX-2 induction by nickel compounds.
    Zhang D; Li J; Wu K; Ouyang W; Ding J; Liu ZG; Costa M; Huang C
    Carcinogenesis; 2007 Apr; 28(4):883-91. PubMed ID: 17065197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. JNK1 but not JNK2 promotes the development of steatohepatitis in mice.
    Schattenberg JM; Singh R; Wang Y; Lefkowitch JH; Rigoli RM; Scherer PE; Czaja MJ
    Hepatology; 2006 Jan; 43(1):163-72. PubMed ID: 16374858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Jnk1 Deficiency in Hematopoietic Cells Suppresses Macrophage Apoptosis and Increases Atherosclerosis in Low-Density Lipoprotein Receptor Null Mice.
    Babaev VR; Yeung M; Erbay E; Ding L; Zhang Y; May JM; Fazio S; Hotamisligil GS; Linton MF
    Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1122-31. PubMed ID: 27102962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective role of c-Jun N-terminal kinase-2 (JNK2) in ibuprofen-induced acute liver injury.
    Zoubek ME; Woitok MM; Sydor S; Nelson LJ; Bechmann LP; Lucena MI; Andrade RJ; Bast A; Koek GH; Trautwein C; Cubero FJ
    J Pathol; 2019 Jan; 247(1):110-122. PubMed ID: 30264435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. JNK1 is not essential for TNF-mediated joint disease.
    Köller M; Hayer S; Redlich K; Ricci R; David JP; Steiner G; Smolen JS; Wagner EF; Schett G
    Arthritis Res Ther; 2005; 7(1):R166-73. PubMed ID: 15642137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of novel regulators of osteoblast matrix mineralization by time series transcriptional profiling.
    Staines KA; Zhu D; Farquharson C; MacRae VE
    J Bone Miner Metab; 2014 May; 32(3):240-51. PubMed ID: 23925391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiapoptotic effect of c-Jun N-terminal Kinase-1 through Mcl-1 stabilization in TNF-induced hepatocyte apoptosis.
    Kodama Y; Taura K; Miura K; Schnabl B; Osawa Y; Brenner DA
    Gastroenterology; 2009 Apr; 136(4):1423-34. PubMed ID: 19249395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A JNK1/AP-1-dependent, COX-2 induction is implicated in 12-O-tetradecanoylphorbol-13-acetate-induced cell transformation through regulating cell cycle progression.
    Zhang D; Li J; Song L; Ouyang W; Gao J; Huang C
    Mol Cancer Res; 2008 Jan; 6(1):165-74. PubMed ID: 18234971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TBP is differentially regulated by c-Jun N-terminal kinase 1 (JNK1) and JNK2 through Elk-1, controlling c-Jun expression and cell proliferation.
    Zhong S; Fromm J; Johnson DL
    Mol Cell Biol; 2007 Jan; 27(1):54-64. PubMed ID: 17074809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.